RUNNING POINT CAPITAL ADVISORS, LLC Adaptimmune Therapeutics plc Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$11,000
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -6K $1.08 10K
Q2 2022 share 0.00% 0 shares -4K $1.7 10K
Q1 2022 share Increase 0.00% 10K shares 21K $2.06 10K